Transposition of the great vessels epidemiology and demographics: Difference between revisions
(New page: {{Template:Transposition of the great vessels}} {{CMG}} ==Epidemiology and demographics== Transposition of the great arteries TGA is one of the most common cyanotic congenital heart defec...) |
No edit summary |
||
Line 9: | Line 9: | ||
[[fr:Transposition des gros vaisseaux]] | [[fr:Transposition des gros vaisseaux]] | ||
[[zh:大血管轉位]] | [[zh:大血管轉位]] | ||
Revision as of 15:28, 13 July 2011
Transposition of the great vessels Microchapters |
Classification |
---|
Differentiating Transposition of the great vessels from other Diseases |
Diagnosis |
Treatment |
Surgery |
Case Studies |
Transposition of the great vessels epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Transposition of the great vessels epidemiology and demographics |
FDA on Transposition of the great vessels epidemiology and demographics |
CDC on Transposition of the great vessels epidemiology and demographics |
Transposition of the great vessels epidemiology and demographics in the news |
Blogs on Transposition of the great vessels epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Epidemiology and demographics
Transposition of the great arteries TGA is one of the most common cyanotic congenital heart defects present in the first 24 hours of life. TGA represents 5-7% of all CHD with an incidence at birth of 20-30 in 100000 live births. TGA is more common in infants of diabetic mothers. Boys outnumber girls with an approximate ratio of 2:1. Without treatment, 30% of infants die within the first week of life, 50% will die in the first month, 70% will die in the first 6 months and 90% of infants will die before the end of the first year. 4.9% of patients have associated extracardiac abnormalities.